Cancer Stem Cells Market
According to Intent Market Research, the Cancer Stem Cells Market is expected to grow from USD 3.4 billion in 2024-e at a CAGR of 10.5% to touch USD 6.2 billion by 2030. The Cancer Stem Cells Market is dominated by key players such as, Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Creative Bioarray, and Cell Biolabs, Inc..